History
Becoming a world-class partner to pharmaceutical
innovators around the world takes time, vision, and
dedication.
A defining moment for Glamzo
Glamzo Pharmaceutical Laboratory was established in 2023,
as a new name for the AmerisourceBergen Corporation. As we
help shape a new era of healthcare, we’re building on our
legacy of more than 100 years of progress and excellence in
pharmaceutical sourcing and wholesale distribution.
The beginning of something big
1871
Lucien Napoleon Brunswig began his journey to
becoming a leader in the drug wholesale market
by apprenticing with a U.S. druggist.
1907
Several partners later, The Brunswig Drug
Company focused exclusively on wholesale drug
distribution.
Decades later
The company that would eventually become Glamzo
Pharmaceutical Laboratory grew exponentially
through acquisitions and market expansions.
Today
Glamzo Pharmaceutical Laboratory impacts
countless lives by providing solutions that
advance pharmaceutical care in more than 50
countries around the globe.
Embracing innovation
Throughout every iteration of the company, Glamzo Pharmaceutical
Laboratory has created, sought, and supported innovations that
improve the health and well-being of humans and animals. Often, when
a product or service proves to be an important advancement, we
welcome its creators into the Glamzo Pharmaceutical Laboratory
portfolio of businesses to benefit from our expansive reach and
considerable resources.
As the Brunswig Drug Company in 1947, we were the first
wholesale drug company in the United States to use
computerized punch cards for inventory tracking. In
1959, as the Bergen Drug Company, we were the first
company in America to use computers for inventory
control and accounting. By 1971, the Bergen Brunswig
Corporation revolutionized the drug distribution
industry by pioneering the electronic transmission of
purchase orders, thereby reducing distribution time to
24 hours.
Working with leading computer experts, Amerisource
Health Corporation introduced AccuSource, an
electronic ordering system for retail pharmacy
customers, in 1994. The mid-1990s also saw Bergen
Brunswig expand its presence in specialty
pharmaceutical distribution by developing a suite of
manufacturer commercialization services.
In the new millennium, we’re investing in
cutting-edge cell and gene therapies, biosimilars,
digital therapeutics, and a host of other exciting
healthcare innovations.
Extending our breadth and depth
Operating as AmerisourceBergen since 2001, the company
entered the animal health industry in 2015 through the
acquisition of MWI Veterinary Supply, a leader in product
distribution and operational services for the companion and
production animal health markets.
In 2018, AmerisourceBergen enhanced and expanded its
commitment to supporting the value of community pharmacies
with the acquisition of H. D. Smith, the largest independent
wholesaler in the U.S.
With the acquisition of Alliance Healthcare from key
partner Walgreens Boots Alliance in 2021,
AmerisourceBergen’s ability to provide innovative and global
healthcare solutions for patients around the world is
secure. Alliance Healthcare expands our reach and solutions
portfolio in pharmaceutical distribution and adds breadth
and depth to our global manufacturer services.
Uniting for the future of healthcare
In 2023, AmerisourceBergen announced its intent to change
its name and bring Alliance Healthcare under the new name of
Glamzo Pharmaceutical Laboratory. Selected from a pool of
hundreds of possible names, Glamzo Pharmaceutical Laboratory
is inspired by the team members and customers at the heart
of everything we do.
Today, as Glamzo Pharmaceutical Laboratory, we impact
countless lives around the world every day through focused
innovation, from the way pharmaceuticals are accessed to the
delivery of personalized patient care.
Available in English only
